Tue12112018

Robins Global News & Noticias



  • Odds: Packers vs. Bears
    Odds: Packers vs. Bears
  • Featured Guest Post
    Featured Guest Post
  • Publicación de invitado destacado
    Publicación de invitado destacado
  • Trump Pence News
    Trump Pence News
  • Weather Alerts
    Weather Alerts

Special News Reports

+ Larger Font | + Smaller Font

Globe NewsWire News Distribution Service

Press Release: Verrica Pharmaceuticals Inc. Announces Pricing of Initial Public Offering


WEST CHESTER, Pa., June 14, 2018 (GLOBE NEWSWIRE) -- Verrica Pharmaceuticals Inc. (“Verrica”) (Nasdaq:VRCA), a pharmaceutical company focused on identifying, developing and commercializing innovative pharmaceutical products for the treatment of skin diseases with significant unmet needs, today announced the pricing of its initial public offering of 5,000,000 shares of its common stock at a public offering price of $15.00 per share, for total gross proceeds of approximately $75.0 million before underwriting discounts and commissions and estimated offering expenses.  In addition, Verrica has granted the underwriters a 30-day option to purchase up to an additional 750,000 shares of common stock at the public offering price, less underwriting discounts and commissions. All of the common stock is being offered by Verrica. The shares are scheduled to begin trading on the Nasdaq Global Market on June 15, 2018 under the ticker symbol “VRCA.” The offering is expected to close on June 19, 2018, subject to customary closing conditions.
BofA Merrill Lynch, Jefferies and Cowen are serving as joint book-running managers for the offering.A registration statement relating to the securities being sold in this offering was declared effective by the Securities and Exchange Commission on June 14, 2018.  This offering is being made only by means of a prospectus.  A copy of the final prospectus can be obtained, when available, from: BofA Merrill Lynch, NC1-004-03-43, 200 North College Street, 3rd Floor, Charlotte, NC 28255-0001, Attention: Prospectus Department, or by email at This email address is being protected from spambots. You need JavaScript enabled to view it.; Jefferies, Attention: Equity Syndicate Prospectus Department, 520 Madison Avenue, 2nd Floor, New York, NY 10022, by phone at 1-877-821-7388 or by email at This email address is being protected from spambots. You need JavaScript enabled to view it.; or Cowen, c/o Broadridge Financial Solutions, 1155 Long Island Avenue, Edgewood, NY 11717, Attention: Prospectus Department, or by telephone at (631) 274-2806.This press release shall not constitute an offer to sell, or the solicitation of an offer to buy, nor shall there be any sale of these securities in any state or jurisdiction in which such offer, solicitation, or sale would be unlawful prior to registration or qualification under the securities laws of any such state or jurisdiction.About Verrica Pharmaceuticals Inc.Verrica is a pharmaceutical company focused on identifying, developing and commercializing innovative pharmaceutical products for the treatment of skin diseases with significant unmet needs. The company’s lead product candidate, VP-102, is currently being evaluated in two Phase 3 clinical trials for the treatment of molluscum and in a Phase ...


Posted: 2018-06-14 21:52:00

Get Full News Story On GlobeNewsWire Press Release Service


Listen to this article. Speaker link opens in a new window.
Text To Speech BETA Test Version.






Print Friendly and PDF Share Embed


Related News Stories From The Web And More

Related Bing News

Press Release: Verrica Pharmaceuticals Inc. Announces Pricing of Initial Public Offering | Globe NewsWire News Distribution Service | Special News Reports - Newscast

DIAMEDICA ANNOUNCES PRICING OF INITIAL PUBLIC OFFERING AND NASDAQ LISTING

Fri, 07 Dec 2018 03:00:00 GMT

announced today the pricing of its initial public offering in the United States of 4,100,000 of its common shares at a price to the public of $4.00 per share. All of the common shares are being ...

Synthorx Announces Pricing of Initial Public Offering

Thu, 06 Dec 2018 17:16:00 GMT

News and research before you hear about it on CNBC and others. Claim your 2-week free trial to StreetInsider Premium here. SAN DIEGO, Dec. 06, 2018 (GLOBE NEWSWIRE) -- Synthorx, Inc. (Nasdaq: THOR), a ...

Moderna Announces Pricing of Initial Public Offering

Thu, 06 Dec 2018 16:40:00 GMT

Moderna, Inc. MRNA, +0.00% a clinical stage biotechnology company pioneering messenger RNA (mRNA) therapeutics and vaccines to create a new generation of transformative medicines for patients, today a...

Aptorum Group Limited Announces Pricing of Initial Public Offering

Thu, 06 Dec 2018 08:33:00 GMT

Aptorum Group Limited (“Aptorum”, or the “Company”), a Hong Kong based pharmaceutical company currently in the preclinical stage, dedicated to developing and commercializing therapeutic projects and d...

TLC Announces Pricing of Initial Public Offering of American Depositary Shares (ADSs) on Nasdaq

Tue, 20 Nov 2018 16:00:00 GMT

TAIPEI, Taiwan and SOUTH SAN FRANCISCO, Calif., Nov. 21, 2018 (GLOBE NEWSWIRE) -- Taiwan Liposome Company, Ltd. (4152.TWO) (TLC), a clinical-stage specialty pharmaceutical company dedicated to the dev...

Related Bing Web Search

Twist Bioscience Corporation Announces Pricing of Initial ...

(Tue, 30 Oct 2018 21:10:00 GMT)

In addition, Twist has granted the underwriters a 30-day option to purchase up to an additional 750,000 shares at the initial public offering price, less the underwriting discounts and commissions.

Initial Public Offering - IPO - Investopedia

(Tue, 19 May 2015 19:21:00 GMT)

An initial public offering is when a private company or corporation raises investment capital by offering its stock to the public for the first time.

Moderna Announces Pricing of Initial Public Offering ...

(Thu, 06 Dec 2018 20:33:00 GMT)

Moderna Announces Pricing of Initial Public Offering. ... today announced the pricing of its initial public offering of 26,275,993 shares of common stock at a public offering price of $23.00 per ...

PhaseBio Announces Pricing of Initial Public Offering ...

(Fri, 07 Dec 2018 00:37:00 GMT)

PhaseBio Announces Pricing of Initial Public Offering. PDF Version. ... today announced the pricing of its initial public offering of 9,200,000 shares of common stock at a price to the public of $5.00 per share, for total gross proceeds of approximately $46.0 million. ...

Synthorx Announces Pricing of Initial Public Offering ...

(Fri, 07 Dec 2018 14:27:00 GMT)

Synthorx Announces Pricing of Initial Public Offering. ... today announced the pricing of its initial public offering of 11,912,727 shares of common stock at a public offering price of $11.00 per ...

Elastic Announces Pricing of Initial Public Offering ...

(Thu, 04 Oct 2018 06:53:00 GMT)

In addition, Elastic has granted the underwriters a 30-day option to purchase up to 1,050,000 additional ordinary shares at the initial public offering price less the underwriting discount.

Aptinyx Announces Pricing of Initial Public Offering

(Wed, 20 Jun 2018 13:38:00 GMT)

In addition, Aptinyx has granted the underwriters a 30-day option to purchase 959,999 additional shares of common stock at the initial public offering price, less underwriting discounts and ...

CNFinance Announces Pricing of Initial Public Offering

(Tue, 06 Nov 2018 21:59:00 GMT)

The underwriters have been granted an option, exercisable within 30 days from the date of the final prospectus, to purchase up to 975,000 additional ADSs at the initial public offering price less ...

Autolus Announces Pricing of Initial Public Offering

(Fri, 22 Jun 2018 01:47:00 GMT)

In addition, Autolus has granted the underwriters a 30-day option to purchase up to an additional 1,323,529 ADSs at the initial public offering price, less underwriting discounts and commissions.

Arvinas Announces Pricing of Initial Public Offering | Arvinas

(Fri, 07 Dec 2018 09:19:00 GMT)

The offering is expected to close on October 1, 2018, subject to customary closing conditions. Goldman Sachs & Co. LLC, Citigroup and Piper Jaffray & Co., are acting as joint book-running managers for the offering.

Related News Story Videos From Youtube

Athene Holding Ltd. Announces the Pricing of Its Initial Public Offering


Related Videos On: Athene Holding Ltd. Announces the Pricing of Its Initial Public Offering


Aquantia Announces Pricing of Initial Public Offering


Related Videos On: Aquantia Announces Pricing of Initial Public Offering


Quanterix Corporation Announces Pricing of Initial Public Offering


Related Videos On: Quanterix Corporation Announces Pricing of Initial Public Offering


Lyft Files To Go Public With Stock Shares


Related Videos On: Lyft Files To Go Public With Stock Shares


Breaking News: High Times PRE-IPO (HITM) $11.2 Million Dope Media Acquisition


Related Videos On: Breaking News: High Times PRE-IPO (HITM) $11.2 Million Dope Media Acquisition






Blow Us A Whistle

Comments (Whistles) Designed By Disqus




Company Information

Official Content Providers











PRIVACY POLICY

We recommend Firefox 3 (and above), Edge, and Chrome for dynamic performance.
© 2008-2018 RobinsPost (The Bird's Eye View Company) All rights are reserved.
RobinsPost provides links to news sites based on their RSS feeds.
All trademarks, copyrights, videos, photos and logos are owned by news sources.
News stories, videos and live streams are from trusted sources.
ROBINSPOST Is Proudly Made In America.
Where Quality, Safety and Service Comes First.